Financial Summary (All financials)
In millions, except per share items | Dec-31-04 | Dec-26-03 | Dec-27-02 | Dec-28-01 | Dec-29-00 |
Revenues | 2,224.0 | 2,182.6 | 2,039.6 | 2,045.3 | 2,060.2 |
Revenue growth | 1.9% | 7.0% | -0.3% | -0.7% | |
Cost of goods sold | 1,170.4 | 1,186.6 | 1,125.1 | 1,144.9 | 1,228.7 |
Gross profit | 1,053.6 | 996.0 | 914.5 | 900.5 | 831.5 |
Gross margin | 47.4% | 45.6% | 44.8% | 44.0% | 40.4% |
Selling, general and administrative | 634.9 | 598.5 | 561.3 | 557.5 | 569.7 |
Research and development | 196.7 | 204.4 | 215.0 | 244.5 | |
EBIT | 221.9 | 193.1 | 138.2 | 98.5 | 4.0 |
EBIT margin | 10.0% | 8.8% | 6.8% | 4.8% | 0.2% |
Pre-tax income | 236.9 | 201.9 | 146.3 | 101.8 | -2.7 |
Income taxes | 45.9 | 53.0 | 36.3 | 34.6 | -1.0 |
Tax rate | 19.4% | 26.2% | 24.8% | 34.0% | 35.0% |
Net income | 191.0 | 148.9 | 110.0 | 67.2 | -1.8 |
Net margin | 8.6% | 6.8% | 5.4% | 3.3% | -0.1% |
|
Diluted EPS | $1.72 | $1.35 | $1.02 | $0.65 | ($0.02) |
Shares outstanding (diluted) | 111.2 | 110.6 | 107.4 | 103.1 | 100.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|